These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26297117)

  • 1. Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.
    Lee K; Jun SH; Song SH; Park HD; Park KU; Song J
    Clin Biochem; 2015 Dec; 48(18):1350-3. PubMed ID: 26297117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome).
    Wolfe BJ; Blanchard S; Sadilek M; Scott CR; Turecek F; Gelb MH
    Anal Chem; 2011 Feb; 83(3):1152-6. PubMed ID: 21192662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease).
    Wang D; Wood T; Sadilek M; Scott CR; Turecek F; Gelb MH
    Clin Chem; 2007 Jan; 53(1):137-40. PubMed ID: 17082248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-Based Newborn Screening for Mucopolysaccharidosis Type II in Illinois: The First Year Experience.
    Burton BK; Hoganson GE; Fleischer J; Grange DK; Braddock SR; Hickey R; Hitchins L; Groepper D; Christensen KM; Kirby A; Moody C; Shryock H; Ashbaugh L; Shao R; Basheeruddin K
    J Pediatr; 2019 Nov; 214():165-167.e1. PubMed ID: 31477379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brazilian reference values for MPS II screening in dried blood spots--a fluorimetric assay.
    Rezende MM; Müller KB; Pereira VG; D'Almeida V
    Clin Biochem; 2014 Sep; 47(13-14):1297-9. PubMed ID: 24979053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples.
    Dean CJ; Bockmann MR; Hopwood JJ; Brooks DA; Meikle PJ
    Clin Chem; 2006 Apr; 52(4):643-9. PubMed ID: 16497940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type II (Hunter syndrome)].
    Zhang WM; Shi HP; Li BT; Zhao SM; Qi QW; Sun NH; Huang SZ
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):644-7. PubMed ID: 17217652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
    Voznyi YV; Keulemans JL; van Diggelen OP
    J Inherit Metab Dis; 2001 Nov; 24(6):675-80. PubMed ID: 11768586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots.
    Tolun AA; Graham C; Shi Q; Sista RS; Wang T; Eckhardt AE; Pamula VK; Millington DS; Bali DS
    Mol Genet Metab; 2012 Mar; 105(3):519-21. PubMed ID: 22227323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.
    Johnson BA; van Diggelen OP; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2013 Oct; 79():17.14.1-17.14.9. PubMed ID: 24510650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
    Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
    Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R
    Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
    Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
    Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome).
    Gusarova VD; Smolov MA; Lyagoskin IV; Degterev MB; Rechetnik EV; Rodionov AV; Pantyushenko MS; Shukurov RR
    BioDrugs; 2023 May; 37(3):375-395. PubMed ID: 37014547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
    Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of tandem mass spectrometry for newborn screening of 6 lysosomal storage disorders in a Korean population.
    Han M; Jun SH; Song SH; Park KU; Kim JQ; Song J
    Korean J Lab Med; 2011 Oct; 31(4):250-6. PubMed ID: 22016678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for galactosemia by a second-tier multiplex enzyme assay using UPLC-MS/MS in dried blood spots.
    Ko DH; Jun SH; Park KU; Song SH; Kim JQ; Song J
    J Inherit Metab Dis; 2011 Apr; 34(2):409-14. PubMed ID: 21340634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.